Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06054659 · ClinicalTrials.gov registry record · NA

CGM and DFU Healing Post-discharge

A NA study of Diabetic Foot and Diabetes Type 2 With Diabetic Ulcer of Toe, Skin Breakdown, sponsored by Emory University.

Active
Registry status
NA
Development phase
116
Enrollment target
2
Study locations

NCT06054659 is a NA study of Diabetic Foot and Diabetes Type 2 With Diabetic Ulcer of Toe, Skin Breakdown that is active but no longer recruiting, run by Emory University. The registered enrollment target is 116 participants, below the 10,337-participant average among 30 other Diabetic Foot trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06054659, a NA study of Diabetic Foot and Diabetes Type 2 With Diabetic Ulcer of Toe, Skin Breakdown, is active but no longer recruiting, sponsored by Emory University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
116 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to look at the benefits of using a Continuous Glucose Monitoring (CGM) system compared with standard-of-care testing for patients with type 2 diabetes and diabetic foot ulcers (DFU) and how this will improve wound healing. The CGM system allows medical staff and patients with diabetes to monitor and make treatment decisions to improve glucose control, without the need for performing fingersticks. Hence, the use of CGM will decrease the painful and burdensome task of performing finger sticks several times per day and may prevent low blood glucose in patients with diabetes.

Interventions

  • BEHAVIORAL Diabetes Education
  • DEVICE Real Time Continuous Glucose Monitoring (rt-CGM)
  • OTHER Fingerstick blood glucose (FBG) monitoring

Study Locations (2)

Georgia

  • Grady Health System - Atlanta
  • Emory Decatur Hospital - Decatur

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 2024-02-20
Est. Completion 2026-02
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT06054659

The ClinicalTrials.gov registry entry for NCT06054659 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 10,337-participant average among 30 other Diabetic Foot trials with a reported enrollment target (99% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetic Foot appearing as the primary indexed condition, and to 3 interventions - of which Diabetes Education is the first listed.

NCT06054659 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT06054659 about?

NCT06054659 is a clinical study titled "CGM and DFU Healing Post-discharge". The purpose of this study is to look at the benefits of using a Continuous Glucose Monitoring (CGM) system compared with standard-of-care testing for patients with type 2 diabetes and diabetic foot ulcers (DFU) and how this will improve wound healing. The CGM system allows medical staff and patient...

What is the current status of trial NCT06054659?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 116 participants. The study started on 2024-02-20. Estimated completion is 2026-02.

What conditions does trial NCT06054659 study?

This clinical trial studies the following conditions: Diabetic Foot, Diabetes Type 2 With Diabetic Ulcer of Toe, Skin Breakdown.

What interventions are being tested in trial NCT06054659?

The interventions under investigation include: Diabetes Education (BEHAVIORAL), Real Time Continuous Glucose Monitoring (rt-CGM) (DEVICE), Fingerstick blood glucose (FBG) monitoring (OTHER).

Who is sponsoring clinical trial NCT06054659?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06054659 being conducted?

This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetic Foot

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.